undefined undefined
NaN.000
NaN.00%
Leerink Partners analyst Puneet Souda has maintained their bullish stance on EX...
05-16 16:14
Goldman Sachs analysts identified short-term overwriting opportunities in large-cap, high implied volatility stocks that do not have earnings events. Analysts said that event timing and stock characte...
05-15 22:43
Citigroup analyst Patrick Donnelly maintains Exact Sciences (NASDAQ:EXAS) with a Buy and lowers the price target from $100 to $80.
05-10 01:54
Emerson Electric Co (NYSE:EMR) posted better-than-expected results for its seco...
05-09 19:56
Exact Sciences said first-quarter revenue increased 6% year-over-year to $638 million, which beat the consensus estimate of $627.355 million, according to Benzinga Pro. The company reported a quarterly loss of 60 cents per share, which missed analyst estimates for a loss of 48 cents per share.
05-09 05:23
Exact Sciences (EXAS – Research Report), the Healthcare sector company, was rev...
05-08 11:55
As Wall Street embarks on the first full week of May, a diverse group of companies is set to report financial results. Notable names include The Walt Disney Company (NYSE:DIS), Palantir Technologies...
05-05 20:00
Exact Sciences Corp. (EXAS) just unveiled an update. Dr. Freda Lewis-Hall, a bo...
04-26 04:45
近日, 安徽皖仪科技股份有限公司 (以下简称皖仪科技) 与中国分析测试协会高校分析测试分会 (以下简称高校分会) 携手合作,签署战略合作项目,设立“皖仪科技”卓...
04-23 18:53
To help facilitate a smooth transition, Bloomer joins the company as executive vice president, finance, effective immediately, and will succeed Jeff Elliott following a 30-day transition period. As previously announced,
04-15 18:01